Unterzeichnung(en)
Übersicht
The proposed operation concerns the financing of Livanova's research and development (R&D) activities in the cardiac surgery and cardiac rhythm management franchises.
The operation targets the promoter's research, development and innovation (RDI) activities for the development of new products and technologies in the cardiac surgery and cardiac rhythm management sectors. The activities will be carried out in Italy and France in the period 2017 to 2019.
The project concerns investments in research and development that are expected to be carried out in existing facilities, already authorised, and which would therefore not require an environmental impact assessment (EIA) under Directive 2011/92/EU. Full environmental details will be verified during the appraisal.
The promoter is a private company not operating in the utilities sector, and is thus not covered by EU directives on procurement.